跳至主要内容
临床试验/NCT03212781
NCT03212781已完成3 期

Total Dose Infusion of Iron Dextran Versus Oral Iron for Treating Iron Deficiency Anemia in Pregnant Women: a Randomized Controlled Trial

Assiut University1 个研究点 分布在 1 个国家目标入组 66 人开始时间: 2016年6月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
3 期
状态
已完成
入组人数
66
试验地点
1
主要终点
The change in Hemoglobin concentration from baseline to 8 weeks therapy

研究概览

简要总结

Iron deficiency is the most prevalent nutritional deficiency and the most common cause of anemia .It is characterized by a defect in hemoglobin synthesis, resulting in red blood cells that are abnormally small (microcytic) and contain a decreased amount of hemoglobin (hypochromic).

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 45 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • Hemoglobin < 10 g/dL
  • Gestational age between 14-28 weeks.
  • Willingness to participate and signing the informed consent form.

排除标准

  • Iron overload or disturbances in utilization of iron
  • Decompensated liver cirrhosis and active hepatitis
  • Active acute or chronic infections
  • History of multiple allergies
  • Known hypersensitivity to parenteral iron or any recipients in the investigation drug products
  • Erythropoietin treatment within 8 weeks prior to the screening visit
  • Other iron treatment or blood transfusion within 4 weeks prior to the screening visit
  • Planned elective surgery during the study.

研究组 & 干预措施

intravenous iron

Experimental

patients will receive intravenous iron as total dose infusion

干预措施: Iron dextran (Drug)

oral iron

Active Comparator

patients will receive oral iron

干预措施: Ferrous Fumarate (Drug)

结局指标

主要结局

The change in Hemoglobin concentration from baseline to 8 weeks therapy

时间窗: 8 weeks

measure hemoglobin level before and after treatment

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Ahmed Mohamed Abbas

Principal investigator

Assiut University

研究点 (1)

Loading locations...

相似试验

Iron Dextran Versus Oral Iron for Treating Iron... | 临床试验